Fairfield Financial Advisors’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,536
Closed -$479K 74
2025
Q2
$479K Sell
1,536
-836
-35% -$320K 0.17% 55
2025
Q1
$1.24M Sell
2,372
-1,505
-39% -$769K 0.47% 37
2024
Q4
$1.96M Sell
3,877
-374
-9% -$213K 0.69% 30
2024
Q3
$2.49M Sell
4,251
-58
-1% -$32.8K 0.85% 25
2024
Q2
$2.19M Buy
+4,309
New +$2.11M 0.65% 25
2023
Q4
$2.13M Buy
4,051
+573
+16% +$306K 0.81% 27
2023
Q3
$1.75M Buy
3,478
+882
+34% +$434K 0.74% 30
2023
Q2
$1.25M Buy
2,596
+1,140
+78% +$557K 0.5% 34
2023
Q1
$685K Buy
1,456
+1,064
+271% +$513K 0.3% 41
2022
Q4
$208K Buy
392
+320
+444% +$170K 0.1% 62
2022
Q3
$36.3K Buy
72
+40
+125% +$21K 0.02% 132
2022
Q2
$16.3K Hold
32
0.01% 174
2022
Q1
$16.1K Buy
+32
New +$15.4K 0.01% 191

Other funds holding UNH

Fairfield Financial Advisors's UNH Position: Q3 2025 in Review

Fairfield Financial Advisors sold out of UnitedHealth (UNH) in Q3 2025, closing a stake of 1,536 shares — an estimated $479K sold.

Fairfield Financial Advisors first reported a position in UNH in Q1 2022 and held it in 13 quarters. The position peaked at $2.49M in Q3 2024. 3,159 funds tracked by Wall St. Rank hold UNH as of Q3 2025.

  • Fairfield Financial Advisors reported no remaining UnitedHealth position as of Q3 2025 after selling out during the quarter.
  • Fairfield Financial Advisors sold 1,536 UnitedHealth shares in Q3 2025, an estimated $479K.
  • Fairfield Financial Advisors first reported a position in UnitedHealth in Q1 2022 and held it in 13 quarters.
  • Fairfield Financial Advisors's UnitedHealth position peaked at $2.49M in Q3 2024.
  • 3,159 funds tracked by Wall St. Rank held UnitedHealth as of Q3 2025.

Based on Fairfield Financial Advisors's 13F filing for Q3 2025, filed 24 Oct 2025.